Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Overview and recent advances in the treatment of neuroblastoma.
Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Whittle SB, et al. Expert Rev Anticancer Ther. 2017 Apr;17(4):369-386. doi: 10.1080/14737140.2017.1285230. Epub 2017 Mar 15. Expert Rev Anticancer Ther. 2017. PMID: 28142287 Free article. Review.
Blood product administration during high risk neuroblastoma therapy.
Silverstein A, Reddy K, Smith V, Foster JH, Russell HV, Whittle SB. Silverstein A, et al. Among authors: whittle sb. Pediatr Hematol Oncol. 2020 Feb;37(1):5-14. doi: 10.1080/08880018.2019.1668095. Epub 2019 Dec 12. Pediatr Hematol Oncol. 2020. PMID: 31829069 Free PMC article.
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors.
Whittle SB, Smith V, Silverstein A, Parmeter M, Minard CG, Bernhardt MB, Zage PE, Venkatramani R, Nuchtern JG, Heczey A, Russell HV, Shohet JM, Foster JH. Whittle SB, et al. Pediatr Blood Cancer. 2020 Oct;67(10):e28417. doi: 10.1002/pbc.28417. Epub 2020 Jul 30. Pediatr Blood Cancer. 2020. PMID: 32729196 Free PMC article. Clinical Trial.
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
Steffin DHM, Muhsen IN, Hill LC, Ramos CA, Ahmed N, Hegde M, Wang T, Wu M, Gottschalk S, Whittle SB, Lulla PD, Mamonkin M, Omer B, Rouce RH, Heczey A, Metelitsa LS, Grilley BJ, Robertson C, Torrano V, Lapteva N, Gee AP, Rooney CM, Brenner MK, Heslop HE. Steffin DHM, et al. Among authors: whittle sb. Blood. 2022 Jul 7;140(1):16-24. doi: 10.1182/blood.2022015728. Blood. 2022. PMID: 35325065 Free PMC article.
Soft Tissue and Visceral Organ Sarcomas With BCOR Alterations.
Whittle SB, Fetzko S, Roy A, Venkatramani R. Whittle SB, et al. J Pediatr Hematol Oncol. 2022 Jul 1;44(5):195-200. doi: 10.1097/MPH.0000000000002480. Epub 2022 May 4. J Pediatr Hematol Oncol. 2022. PMID: 35537005 Free PMC article.
26 results